Defining bowel dose volume constraints for bladder radiotherapy treatment planning.

Published on Jan 1, 2015in Clinical Oncology3.113
· DOI :10.1016/J.CLON.2014.09.016
Fiona McDonald20
Estimated H-index: 20
(The Royal Marsden NHS Foundation Trust),
Rachel Waters14
Estimated H-index: 14
+ 3 AuthorsRobert Huddart83
Estimated H-index: 83
(The Royal Marsden NHS Foundation Trust)
Abstract Aims Increases to radiotherapy dose are constrained by normal tissue effects. The relationship between bowel dose volume data and late bowel toxicity in patients with muscle-invasive bladder cancer treated with radical radiotherapy was assessed. Materials and methods The bowel was contoured retrospectively on radiotherapy plans of 47 patients recruited to the BC2001 trial (CRUK/01/004). The relationship between bowel volume at various dose levels and prospectively collected late bowel toxicity was explored. Results Fifteen per cent and 6% of patients experienced grade 1 and grade 2 or more late bowel toxicity, respectively. The mean bowel volume was significantly less at doses ≥50 Gy in those treated with reduced high dose volume radiotherapy compared with standard radiotherapy. The probability of late bowel toxicity increased as bowel volume increased ( P  ≤ 0.05 for dose levels 30–50 Gy). No grade 2 or more late bowel toxicity was observed in patients with bowel volumes under the thresholds given in the model that predict for 25% probability of late bowel toxicity. Conclusions There is a dose volume effect for late bowel toxicity in radical bladder radiotherapy. We have modelled the probability of late bowel toxicity from absolute bowel volumes to guide clinicians in assessing radical bladder radiotherapy plans. Thresholds predicting for a 25% probability of late bowel toxicity are proposed as dose volume constraints.
📖 Papers frequently viewed together
19 Citations
3 Citations
#1Robert HuddartH-Index: 83
#2Emma HallH-Index: 57
Last. Nicholas D. James (University of Birmingham)H-Index: 66
view all 14 authors...
Purpose To test whether reducing radiation dose to uninvolved bladder while maintaining dose to the tumor would reduce side effects without impairing local control in the treatment of muscle-invasive bladder cancer. Methods and Materials In this phase III multicenter trial, 219 patients were randomized to standard whole-bladder radiation therapy (sRT) or reduced high-dose volume radiation therapy (RHDVRT) that aimed to deliver full radiation dose to the tumor and 80% of maximum dose to the uninv...
67 CitationsSource
#1Bahman Emami (Loyola University Medical Center)H-Index: 56
367 Citations
#1Nicholas D. James (University of Birmingham)H-Index: 66
#2Syed A. HussainH-Index: 32
Last. Robert HuddartH-Index: 83
view all 12 authors...
In this multicenter, phase 3 trial, we randomly assigned 360 patients with muscleinvasive bladder cancer to undergo radiotherapy with or without synchronous chemotherapy. The regimen consisted of fluorouracil (500 mg per square meter of bodysurface area per day) during fractions 1 to 5 and 16 to 20 of radiotherapy and mitomycin C (12 mg per square meter) on day 1. Patients were also randomly assigned to undergo either whole-bladder radiotherapy or modified-volume radiotherapy (in which the volum...
480 CitationsSource
#1Farshad Foroudi (Peter MacCallum Cancer Centre)H-Index: 27
#2John Wong (Peter MacCallum Cancer Centre)H-Index: 78
Last. Gillian Duchesne (Peter MacCallum Cancer Centre)H-Index: 34
view all 12 authors...
Purpose To determine the advantages and disadvantages of daily online adaptive image-guided radiotherapy (RT) compared with conventional RT for muscle-invasive bladder cancer. Methods and Materials Twenty-seven patients with T2–T4 transitional cell carcinoma of the bladder were treated with daily online adaptive image-guided RT using cone-beam computed tomography (CBCT). From day 1 daily soft tissue–based isocenter positioning was performed using CBCT images acquired before treatment. Using a co...
93 CitationsSource
#1L.B. Hysing (Haukeland University Hospital)H-Index: 12
#2Matthias SöhnH-Index: 16
Last. Markus AlberH-Index: 32
view all 4 authors...
Abstract Background and purpose The aim of this work was to develop a statistical method for generation of patient-specific planning organ-at-risk volumes (PRVs) for the small bowel (SB), by efficient use of a few repeat CT scans. Materials and methods The PRVs are generated from a coverage probability (CP) matrix of the small bowel wall (SBW) by thresholding. To estimate the CPs, we extend a previously published ‘relative frequency of coverage' approach by adding a ‘soft margin' around each SBW...
14 CitationsSource
#1Laura Tuomikoski (HYKS: Helsinki University Central Hospital)H-Index: 9
#2Juhani Collan (HYKS: Helsinki University Central Hospital)H-Index: 14
Last. Mikko Tenhunen (HYKS: Helsinki University Central Hospital)H-Index: 31
view all 6 authors...
Abstract Background and purpose To evaluate the benefits of adaptive radiotherapy for bladder cancer in decreasing irradiation of small bowel. Material and methods Five patients with muscle invasive bladder cancer received adaptive radiotherapy to a total dose of 55.8–65Gy with daily cone-beam computed tomography scanning. The whole bladder was treated to 45–50.4Gy, followed by a partial bladder boost. The plan of the day was chosen from 3 to 4 pre-planned treatment plans according to the visibl...
66 CitationsSource
Purpose To examine patterns of bladder wall motion during high-dose hypofractionated bladder radiotherapy and to validate a novel adaptive planning method, A-POLO, to prevent subsequent geographic miss. Methods and Materials Patterns of individual bladder filling were obtained with repeat computed tomography planning scans at 0, 15, and 30minutes after voiding. A series of patient-specific plans corresponding to these time-displacement points was created. Pretreatment cone-beam computed tomograp...
60 CitationsSource
#1Peter Hoskin (Mount Vernon Hospital)H-Index: 94
#2Ana M. RojasH-Index: 19
Last. Michele I. SaundersH-Index: 44
view all 4 authors...
Purpose Phase II clinical studies suggest that hypoxic modification with carbogen and nicotinamide (CON) may increase the efficacy of radiotherapy (RT). Patients and Methods Three hundred thirty-three patients with locally advanced bladder carcinoma were randomly assigned to RT alone versus RT with CON. A schedule of either 55 Gy in 20 fractions in 4 weeks or 64 Gy in 32 fractions in 6.5 weeks was used. The primary end point was cystoscopic control at 6 months (CC6m) and secondary end points wer...
219 CitationsSource
#1Anne Vestergaard (Aarhus University Hospital)H-Index: 12
#2J. Søndergaard (Aarhus University Hospital)H-Index: 6
Last. Ludvig Paul Muren (Aarhus University Hospital)H-Index: 31
view all 5 authors...
The urinary bladder shows considerable individual variation in shape and position during a course of radiotherapy (RT). In this study we have developed and compared three different adaptive RT (ART) strategies for bladder cancer involving daily cone beam CT (CBCT) imaging and plan selection. Material and methods. Ten patients treated for bladder cancer had daily CBCTs acquired that were registered online using bony anatomy registration. Seven patients received intensity modulated RT (IMRT) with ...
75 CitationsSource
#1Robert Huddart (ICR: Institute of Cancer Research)H-Index: 83
#2Emma Hall (ICR: Institute of Cancer Research)H-Index: 57
Last. Alison BirtleH-Index: 25
view all 4 authors...
108 CitationsSource
Cited By13
#1R. Jadon (Cardiff University)H-Index: 2
#2Louise Hanna (Cardiff University)H-Index: 10
Last. John Staffurth (Cardiff University)H-Index: 34
view all 4 authors...
Abstract Aims Pelvic radiotherapy adds significantly to the curative treatment of many pelvic malignancies. However, this cure comes at a cost for many patients, where late bowel toxicities, such as faecal incontinence, urgency and diarrhoea, adversely affect quality of life. Despite the implementation of advanced radiotherapy techniques in many centres, there are deficiencies in our knowledge of how to make best use of these techniques to minimise these late toxicities, with dose–volume constra...
#1Andrea BresolinH-Index: 1
#2A. FaiellaH-Index: 5
Last. Cesare CozzariniH-Index: 43
view all 24 authors...
Abstract Background and purpose To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Materials and methods Complete data of 415 patients enrolled in a multi institute, prospective trial (#NCT02803086) treated with radical (31%), adjuvant (33%) and salvage (36%) intent at a median dose to pelvic nodes/lymph-nodal area of 53Gy were available. The most severe change...
#1Shaista HafeezH-Index: 13
#2Amanda Webster (Mount Vernon Hospital)H-Index: 2
Last. Robert HuddartH-Index: 83
view all 20 authors...
Introduction Daily radiotherapy delivered with radiosensitisation offers patients with muscle invasive bladder cancer (MIBC) comparable outcomes to cystectomy with functional organ preservation. Most recurrences following radiotherapy occur within the bladder. Increasing the delivered radiotherapy dose to the tumour may further improve local control. Developments in image-guided radiotherapy have allowed bladder tumour-focused ‘plan of the day’ radiotherapy delivery. We aim to test within a rand...
3 CitationsSource
#1Aswin Abraham (Cross Cancer Institute)H-Index: 1
#1Aswin G. Abraham (Cross Cancer Institute)H-Index: 6
Last. Kurian Joseph (Cross Cancer Institute)H-Index: 13
view all 13 authors...
Abstract Aim The aim of this study was to identify dosimetric parameters that predict late small bowel (SB) toxicity following neo-adjuvant long course chemoradiation (CRT) for rectal cancer. Materials and Methods 486 consecutive patients with locally advanced rectal cancers (clinical T3/T4 or N1/N2) who received CRT followed by surgery and had dosimetric data available for analysis were included in this study. The dose-volume relationship between small bowel irradiation and late small bowel tox...
#1M.P. Tan (The Royal Marsden NHS Foundation Trust)H-Index: 1
#2V. Harris (Guy's and St Thomas' NHS Foundation Trust)H-Index: 1
Last. Robert Huddart (The Royal Marsden NHS Foundation Trust)H-Index: 83
view all 13 authors...
Abstract Aims Node-positive bladder cancer (NPBC) carries a poor prognosis and has traditionally been treated palliatively. However, surgical series suggest that a subset of NPBC patients can achieve long-term control after cystectomy and lymph node dissection. There is little published data regarding the use of radiotherapy to treat NPBC patients. This is in part due to concerns regarding the toxicity of whole-pelvis radiotherapy using conventional techniques. We hypothesised that, using intens...
2 CitationsSource
#1Alexander D. Sherry (Vandy: Vanderbilt University)H-Index: 5
#2Adam StewartH-Index: 1
Last. Austin N. Kirschner (VUMC: Vanderbilt University Medical Center)H-Index: 11
view all 4 authors...
Objective Intensity-modulated radiation therapy (IMRT) using a volumetric-modulated arc therapy technique may offer dosimetric and clinical benefits compared to the historical standard of care 3D conformal radiotherapy (3D-CRT) in definitive treatment of bladder cancer. We hypothesized that IMRT with CBCT would reduce dose to the rectum, bowel, and bladder compared to 3D-CRT.
1 CitationsSource
#1Ane L Appelt (St James's University Hospital)H-Index: 15
#2E.M. Kerkhof (LUMC: Leiden University Medical Center)H-Index: 10
Last. Corrie A.M. Marijnen (LUMC: Leiden University Medical Center)H-Index: 67
view all 11 authors...
Abstract Background and purpose Organ preservation strategies are increasingly being explored for early rectal cancer. This requires revision of target volumes according to disease stage, as well as new guidelines for treatment planning. We conducted an international, multicentre dose planning study to develop robust planning objectives for modern radiotherapy of a novel mesorectal-only target volume, as implemented in the STAR-TReC trial (NCT02945566). Materials and methods The published litera...
2 CitationsSource
#1R. Jadon (Cardiff University)H-Index: 2
#2Emma Higgins (Cardiff University)H-Index: 1
Last. John Staffurth (Cardiff University)H-Index: 34
view all 6 authors...
Background Advanced pelvic radiotherapy techniques aim to reduce late bowel toxicity which can severely impact the lives of pelvic cancer survivors. Although advanced techniques have been largely adopted worldwide, to achieve their aim, knowledge of which dose-volume parameters of which components of bowel predict late bowel toxicity is crucial to make best use of these techniques. The rectum is an extensively studied organ at risk (OAR), and dose-volume predictors of late toxicity for the rectu...
18 CitationsSource
#1Mareike K. Thompson (Cambridge University Hospitals NHS Foundation Trust)H-Index: 1
#2Philip Poortmans (Curie Institute)H-Index: 56
Last. Charlotte E. Coles (University of Cambridge)H-Index: 39
view all 9 authors...
As we mark 150 years since the birth of Marie Curie, we reflect on the global advances made in radiation oncology and the current status of radiation therapy (RT) research. Large-scale international RT clinical trials have been fundamental in driving evidence-based change and have served to improve cancer management and to reduce side effects. Radiation therapy trials have also improved practice by increasing quality assurance and consistency in treatment protocols across multiple centres. This ...
42 CitationsSource
#1Carla SiniH-Index: 9
Last. Cesare CozzariniH-Index: 43
view all 19 authors...
Abstract Background and purpose Intestinal toxicity is commonly experienced during whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. The aim of the current study was to assess bowel dose–volume relationships for acute patient-reported intestinal symptoms of patients treated with WPRT for prostate cancer. Materials and methods Complete data of 206 patients were available; the median dose to pelvic nodes was 51.8 Gy (range 50.4–54.4, 1.7–2 Gy/fr). Intestinal symptoms were a...
13 CitationsSource